Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells

BACKGROUND: Autologous and allogeneic adult mesenchymal stem/stromal cells (MSCs) are increasingly being investigated for treating a wide range of clinical diseases. Allogeneic MSCs are especially attractive due to their potential to provide immediate care at the time of tissue injury or disease dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Berglund, Alix K., Fortier, Lisa A., Antczak, Douglas F., Schnabel, Lauren V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741939/
https://www.ncbi.nlm.nih.gov/pubmed/29273086
http://dx.doi.org/10.1186/s13287-017-0742-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741939/
https://www.ncbi.nlm.nih.gov/pubmed/29273086
http://dx.doi.org/10.1186/s13287-017-0742-8

Ejemplares similares